Adenocarcinoma of the cervix associated with a neuroendocrine small cell carcinoma of the cervix in the spectrum of Muir-Torre syndrome

Muir-Torre syndrome (MTS) is an autosomal genodermatosis that is diagnosed by the presence of at least one sebaceous gland tumor and at least one visceral malignancy. The most frequent visceral malignancies reported in literature are low-grade colon-rectal and genitourinary cancers, with prolonged survival. The authors report the case of a 52-year-old female, with a positive familial history for MTS, who developed a cutaneous sebaceous carcinoma, a synchronous colon-rectal adenocarcinoma, and a metachronous endocervical adenocarcinoma associated with a neuroendocrine small cell carcinoma of the cervix (SCNC), with lymph node metastasis. The rare occurrence in literature of the cervical SCNC and the rarest occurrence of a neuroendocrine carcinoma in the context of a MTS deviate from the usual and low-grade types of cancers normally described with MTS. It should be always appropriate to assess any symptoms that might reveal an underlying malignancy, although not within the spectrum of neoplasms most associated with this rare syndrome.

Muir-Torre syndrome; Sebaceous carcinoma; Adenocarcinoma; Neuroendocrine small cell carcinoma of the cervix.

[1] Landis M.N, Davis C.L., Bellus G.A.: “Immunosuppression and sebaceous tumors: a confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy”. J. Am. Acad. Dermatol., 2011, 65, 1054.

[2] Davis D.A., Cohen P.R.: “Genitourinary tumors in men with the Muir-Torre syndrome”. J. Am. Acad. Dermatol. 1995, 33, 909.

[3] Akhtar S., Oza K.K., Khan S.A., Wright J.: “Muir-Torre syndrome case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature. J. Am. Acad. Dermatol. 1999, 41, 797.

[4] Cesinaro A.M., Ubiali A., Sighinofili P., Trentini G.P., Gentili F., Facchetti F.: “Mismatch repair proteins expression and microsatellite instability in skin lesions with sebaceous differentiation: a study in different clinical subgroups with and without extracutaneous cancer”. Am. J. Dermatopathol., 2007, 29, 351.

[5] Shalin S.C., Lyle S., Calonje E., Lazar A.J.: “Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications”. Histopathology, 2010, 56, 133.

[6] Higgins H.J., Voutsalath M., Holland J.M.: “Muir-torre syndrome: a case report”. J. Clin. Aesthet. Dermatol., 2009, 2, 30-2

[7] Schwartz R.A., Torre D.P.: “The Muir-Torre syndrome: a 25-year retrospect”. J. Am. Acad. Dermatol., 1995, 33, 90.

[8] Guillén-Ponce C., Castillejo A., Barberá V.M., Pascual-Ramírez J.C., Andrada E., Castillejo M.I., et al.: “Biallelic MYH germline mutations as cause of Muir-Torre syndrome”. Fam. Cancer, 2010, 9, 151.

[9] Muir E.G., Bell A.J., Barlow K.A.: “Multiple primary carcinoma of the colon, duodenum, and larynx associated with kerato- acanthomata of the face”. Br. J. Surg., 1967, 54, 191.

[10] Tokunaga H., Nagase S., Yoshinaga K., Tanaka S., Nagai T., Kurosawa H., et al.: “Small cell carcinoma of the uterine cervix: clinical outcome of concurrent chemoradiotherapy with a multidrug regimen”. Tohoku J. Exp. Med., 2013, 229, 75.

[11] Alphandery C., Dagrada G., Frattini M., Perrone F., Pilotti S.: “Neuroendocrine small cell carcinoma of the cervix associated with endocervical adenocarcinoma: a case report”. Acta Cytol., 2007, 51, 589.

[12] Sorscher S., Saroya B.: “A molecularly confirmed neuroendocrine tumor resulting from Lynch Syndrome”. J. Gastrointest. Oncol., 2013, 4, 95.

[13] Wagner D.G., Gatalica Z., Lynch H.T., Kohl S., Johansson S.L., Lele S.M.: “Neuroendocrine-type prostatic adenocarcinoma with microsatellite instability in a patient with lynch syndrome”. Int. J. Surg. Pathol., 2010, 18, 550.

[14] Miquel C., Sabourin J.C., Elias D., Grandjouan S., Viguier J., Ducreux M.: “An appendix carcinoid tumor in a patient with hereditary non polyposis colorectal cancer”. Hum. Pathol., 2004, 35, 1564.

[15] Rodriguez-Bigas M.A., Vasen H.F., Lynch H.T., Watson P., Myrhøj T., Järvinen H.J., et al.: “Characteristics of small bowel carcinoma in hereditary non-polyposis colorectal carcinoma”. International Collaborative Group on HNPCC”. Cancer, 1998, 83, 240.